Suchbegriffe: PROGRESSION-FREE SURVIVAL - , . Treffer: 4
Steger, GG; Egle, D; Bartsch, R; Pfeiler, G; Petru, E; Greil, R; Helfgott, R; Marth, C; Öhler, L; Hubalek, M; Lang, A; Tinchon, C; Haslbauer, F; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Gnant, M
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Breast. 2020; 50:64-70
Doi: 10.1016/j.breast.2020.01.035
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tepe, G; Zeller, T; Moscovic, M; Corpataux, JM; Christensen, JK; Keirse, K; Nano, G; Schroeder, H; Binkert, CA; Brodmann, M
Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
J Endovasc Ther. 2020; 27(2):304-315
Doi: 10.1177/1526602819898804
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596
Doi: 10.21873/anticanres.13753
Web of Science
PubMed
FullText
FullText_MUG
Richtig, G; Hoeller, C; Wolf, M; Wolf, I; Rainer, BM; Schulter, G; Richtig, M; Grübler, MR; Gappmayer, A; Haidn, T; Kofler, J; Huegel, R; Lange-Asschenfeldt, B; Pichler, M; Pilz, S; Heinemann, A; Richtig, E
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
PLoS One. 2018; 13(10):e0204729-e0204729
Doi: 10.1371/journal.pone.0204729
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG